title: Splenomegaly and thrombosis risk in essential thrombocythemia: the Mayo Clinic experience.
authors.affiliation: Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota.
authors.forename: Mahnur
authors.initials: M
authors.lastname: Haider
authors.affiliation: Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota.
authors.forename: Naseema
authors.initials: N
authors.lastname: Gangat
authors.affiliation: Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
authors.forename: Curtis
authors.initials: C
authors.lastname: Hanson
authors.affiliation: Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota.
authors.forename: Ayalew
authors.initials: A
authors.lastname: Tefferi
mesh_terms: D000328:Adult; D000367:Age Factors; D000368:Aged; D001772:Blood Cell Count; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics; D053208:Kaplan-Meier Estimate; D008297:Male; D008875:Middle Aged; D020125:Mutation, Missense; D016016:Proportional Hazards Models; D018570:Risk Assessment; D012307:Risk Factors; D013163:Splenomegaly / Q000453:epidemiology* / Q000209:etiology; D013920:Thrombocythemia, Essential / Q000150:complications* / Q000235:genetics; D019851:Thrombophilia / Q000209:etiology; D013927:Thrombosis / Q000453:epidemiology* / Q000209:etiology
chemical_list: C507924:JAK2 protein, human; D053614:Janus Kinase 2